Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 8/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | SLC40A1 | Q9NP59 | 12/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.55 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.55 |
| ▸ | G6PD | P11413 | 1/20 | 0.55 |
| ▸ | NFKBIA | P25963 | 1/20 | 0.55 |
| ▸ | METAP2 | P50579 | 1/20 | 0.55 |
| ▸ | METAP1 | P53582 | 1/20 | 0.55 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MITF | O75030 | 1/20 | 0.54 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11469083 | 0.96 | GLO1 (0.69) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL6862349 | 0.95 | GLO1 (0.67) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL11484803 | 0.95 | GLO1 (0.67) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL7189417 | 0.95 | GLO1 (0.67) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL9447062 | 0.85 | GLO1 (0.57) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL11476142 | 0.83 | GLO1 (0.63) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL9446955 | 0.83 | GLO1 (0.54) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL11478242 | 0.81 | GLO1 (0.53) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL9545601 | 0.81 | GLO1 (0.67) | GLO1HTTALOX15SLC40A1TDP1 | |
| SCHEMBL11469225 | 0.80 | GLO1 (0.60) | GLO1HTTALOX15SLC40A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6790540-B2 | COMPLEX OF ZINC, ALUMINUM, COPPER, BERYLLIUM, RUTHENIUM, COBALT, RHODIUM, IRIDIUM OR PLATINUM WITH SULFONAMIDO-SUBSTITUTED AROMATIC COMPOUND; LIQUID CRYSTAL DISPLAYS | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2004-09-14 | — | — | US | disclosed |
| EP-0991624-B1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-11-19 | — | — | EP | disclosed |
| US-20030138663-A1 | Organic electroluminescent element material and organic electroluminescent element | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2003-07-24 | — | — | US | disclosed |
| EP-0991624-A1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | Boehringer Ingelheim Pharma KG (DE) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999000371-A1 | PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138663-A1 | Organic electroluminescent element material and organic electroluminescent element | ELAVL1, AGO2, ELAVL3 | GLO1 1934/4885HTT 4043/4885ALOX15 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.